BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29363089)

  • 1. Extracting Knowledge from MS Clinical Metabolomic Data: Processing and Analysis Strategies.
    Boccard J; Rudaz S
    Methods Mol Biol; 2018; 1730():371-384. PubMed ID: 29363089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
    Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
    Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
    Zhao LK; Zhao YB; Yu PC; Zhang PX
    Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
    Blum BC; Mousavi F; Emili A
    Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galaxy-M: a Galaxy workflow for processing and analyzing direct infusion and liquid chromatography mass spectrometry-based metabolomics data.
    Davidson RL; Weber RJ; Liu H; Sharma-Oates A; Viant MR
    Gigascience; 2016; 5():10. PubMed ID: 26913198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical evaluation of peak capacity improvements by use of liquid chromatography combined with drift tube ion mobility-mass spectrometry.
    Causon TJ; Hann S
    J Chromatogr A; 2015 Oct; 1416():47-56. PubMed ID: 26372446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the IDEOM Workflow for LCMS-Based Metabolomics Studies of Drug Mechanisms.
    Srivastava A; Creek DJ
    Methods Mol Biol; 2020; 2104():419-445. PubMed ID: 31953829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis.
    Chong J; Wishart DS; Xia J
    Curr Protoc Bioinformatics; 2019 Dec; 68(1):e86. PubMed ID: 31756036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two data pre-processing workflows to facilitate the discovery of biomarkers by 2D NMR metabolomics.
    Féraud B; Leenders J; Martineau E; Giraudeau P; Govaerts B; de Tullio P
    Metabolomics; 2019 Apr; 15(4):63. PubMed ID: 30993405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of differential mobility-mass spectrometry for untargeted human plasma metabolomic analysis.
    Wernisch S; Pennathur S
    Anal Bioanal Chem; 2019 Sep; 411(24):6297-6308. PubMed ID: 30941479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches.
    Hsu JY; Hsu JF; Chen YR; Shih CL; Hsu YS; Chen YJ; Tsai SH; Liao PC
    Anal Chim Acta; 2016 Oct; 939():73-83. PubMed ID: 27639145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. El-MAVEN: A Fast, Robust, and User-Friendly Mass Spectrometry Data Processing Engine for Metabolomics.
    Agrawal S; Kumar S; Sehgal R; George S; Gupta R; Poddar S; Jha A; Pathak S
    Methods Mol Biol; 2019; 1978():301-321. PubMed ID: 31119671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What computational non-targeted mass spectrometry-based metabolomics can gain from shotgun proteomics.
    Hamzeiy H; Cox J
    Curr Opin Biotechnol; 2017 Feb; 43():141-146. PubMed ID: 28039739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines.
    Guan W; Zhou M; Hampton CY; Benigno BB; Walker LD; Gray A; McDonald JF; Fernández FM
    BMC Bioinformatics; 2009 Aug; 10():259. PubMed ID: 19698113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Data Preprocessing Using ADAP and MZmine 2.
    Du X; Smirnov A; Pluskal T; Jia W; Sumner S
    Methods Mol Biol; 2020; 2104():25-48. PubMed ID: 31953811
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.